The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant randomized trial of degarelix (Deg) ± cyclophosphamide/GVAX (Cy/GVAX) in men with high-risk prostate cancer (PCa) undergoing radical prostatectomy (RP).
 
Emmanuel S. Antonarakis
Honoraria - Astellas Pharma; Dendreon; ESSA; Janssen Biotech; Medivation; Sanofi
Consulting or Advisory Role - Astellas Pharma; Dendreon; ESSA; Janssen Biotech; Medivation; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Marianna Zahurak
No Relationships to Disclose
 
Edward M. Schaeffer
No Relationships to Disclose
 
Alan W. Partin
Honoraria - International Prostate Cancer Update
Research Funding - Exosome Diagnostics
 
Ashley Ross
Stock and Other Ownership Interests - GenomeDx
Honoraria - Healthtronics
Consulting or Advisory Role - Healthtronics
Research Funding - metamark genetics
 
Mohamad Allaf
Research Funding - Progenics (Inst)
 
Jeffrey Tosoian
No Relationships to Disclose
 
Thomas Nirschl
No Relationships to Disclose
 
Carolyn Chapman
No Relationships to Disclose
 
Tanya Skelton O'Neal
No Relationships to Disclose
 
Haiyi Cao
No Relationships to Disclose
 
Jennifer N. Durham
No Relationships to Disclose
 
Gunes Guner
No Relationships to Disclose
 
Javier Baena Del Valle
No Relationships to Disclose
 
Onur Ertunc
No Relationships to Disclose
 
Angelo Demarzo
Research Funding - Janssen Research & Development; Myriad Genetics
 
Charles G. Drake
Stock and Other Ownership Interests - Compugen; ImmunExcite; NexImmune; Potenza Therapeutics; Tizona Therapeutics, Inc.
Consulting or Advisory Role - Agenus; Astellas Medivation; AstraZeneca/MedImmune; Bristol-Myers Squibb (Inst); Compugen; Dendreon; ImmuneXcite; Janssen Oncology; Lilly; Merck; NexImmune; Pfizer; Pierre Fabre; Potenza Therapeutics; Roche/Genentech; Tizona Therapeutics, Inc.
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patents licensed to BMS (Inst); Patents licensed to Potenza Therapeutics (Inst)